Navigation Links
Crossover

ProductsCrossover
Company Depuy Spine
Item Crossover
Features The Crossover Crossconnectors were designed to have low profile, in both height and run-on-rod, when used with traditional implant systems to minimize interference with bony anatomy and provide room for fusion mass. All connectors include a unique polyaxial feature that allows attachment to a rod at any orientation in the coronal, sagittal and transverse planes. Also, these connectors include an arch in the transverse plane to avoid contact with the dura. One piece crossconnectors, can be used in constructs with any rod diameter (4.75 mm to 6.35 mm), adjustable (length and angulations), anatomic design. Height of connector above the rod less than 4 mm - less than any posterior spinal construct. Run along rod of 8 mm - permits attachment to rod even in tight situations in the lumbar spine. Polyaxial, top loading/top tightening.
Description The Crossover system of implants and instruments provides rotational rigidity to a wide range of posterior rod construct in the thoracic and lumbar spine. The twelve crossconnectors in this system are available in three size ranges: small, medium and large. These cross connectors can be used with the Isola, Pediatric Isola, TiMX, Moss Miami and Monarch systems of implants.
Info Depuy Spine
Customer Service: (800) 227-6633
Web site: http://www.depuyacromed.com/

Related medicine products :

1. Wampole ISOSTAT/ISOLATOR Microbial System
TAG: Crossover
The Vitatron Excellence + lead series are endocardial leads providing excellent handling and optimal pacing characteristics.
The family of Passive Plus DX passive-fixation leads features a 5 mm tip, designed to increase current density and pacing impedance, and a tine fixation, offering versatility and security in lead pla
Selute Picotip Atrial-J steroid eluting passive fixation lead
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),
Medicine Products:
(Date:7/25/2008)...es lung function, increases asthma risk, studies f...ews) -- A clean, fresh-smelling home may actually ...cleaning and air freshening products you use. ,...g products or air fresheners that contain a certai...lorobenzene (1,4 DCB), can reduce lung function by...
(Date:7/25/2008)...umers tips and encourages them to, ,Speak Up,(TM)...ly 25 /PRNewswire-USNewswire/ -- The Pennsylvania,...Patient Safety Day" which,is a national effort to ...te fully in their healthcare by asking questions a...y or illness., "We understand the important role ...
(Date:7/25/2008)...Fourth Annual Physician On-Call Pay ...swire/ -- Sullivan, Cotter and Associates, Inc.,ha...on-call pay rates and,practices, the 2008 Physicia...th data from 132 healthcare organizations nationwi...ates paid for 33 physician specialty areas along,w...
(Date:7/25/2008)...icant Improvements in Members, Health, ATLANTA, J...n health,care quality management solutions for hea...tered into a long-term agreement with Wellmark, In... on Quality(SM) Incent and,Reward Best Practices i...imary care clinicians to promote improved quality ...
Breaking Medicine News(10 mins):Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3
... has confirmed that 22 organizations have joined h...igma and discrimination// associated with AIDS in ...lth and labor companies, the employers group has b...anies that believe in instituting policies to comb...
...F) suggested that people with advanced heart disea...der than their real age.// In a study conduct...examined tissues from heart bypass and transplant ...y cells age. They found that the artery cells d...
...gow University, English cider apples have high lev...ion against stroke, heart// disease and cancer. T...n keeping the doctor away!The scientists plan to t...nteers to drink a pint a day . The volunteers will...
...n genome to date linked to the identifiction of pe...en completed by researchers at// the Molecular Neu... Abuse (NIDA), National Institutes of Health. This...hnology has been used to comprehensively identify ...
Other Medicine News:Health News:Study to Identify People at Risk of Alcoholism 2Health News:Study to Identify People at Risk of Alcoholism 3
(Date:7/23/2008)...ork with Protein Therapeutics that Modul...BRIDGE, Mass., July 23 /- Taligen The...corporate growth plan with the,appointment of Abbi...the,establishment of its headquarters in Cambridge..., a co-founder of the company who remains presiden...
(Date:7/22/2008)...ment Plan Completed Successfully, DUBLIN, Ireland...tion,plc (NASDAQ: AMRN ) today announced that the...ood and Drug Administration (FDA) to discuss the,C... of,hypertriglyceridemia. Following these discussi...101 in hypertriglyceridemia., Dr. Declan Doogan, ...
(Date:7/22/2008)... 22 /- Hyperion,Therapeutics, Inc. to...ment,in its Phase 1/2 clinical trial to evaluate t...ects of HPN-100 (formally called GT4P) versus,BUPH...rea cycle disorders,(UCD). The company plans to an...his year., (Logo: http://www.newscom.com/cgi-bin...
(Date:7/22/2008)...enetic Risk Based on Clinical Data, Preventive ...als, WALTHAM, Mass., July 22 /PRNewswire-FirstCal...day announced the launch of an enhanced test repor... Heart Health Genetic Test.,The test is currently ...lth,Genetic Test by Quixtar/Amway. The new report ...
Breaking Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3Healthcare M 26A Activity on the Rise 9649 1Healthcare M 26A Activity on the Rise 9649 2BD Announces Webcast of Annual Meeting of Shareholders 9646 1New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 1New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 2New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 3New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 4New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 5New Research Shows Nutrition Programs Targeting Pregnancy and First 24 Months of Life Dramatically Improve Child Survival and Overall Health 9643 6OMI Medical Imaging Inc and Affiliated Companies File Chapter 11 Reorganization 9640 1OMI Medical Imaging Inc and Affiliated Companies File Chapter 11 Reorganization 9640 2
...DIEGO--(BUSINESS WIRE)--Mar 14, 2007 - Sequenom, I...RAY(R) technology and,iPLEX(TM) assay were used by...stitutions and, in independent studies, significan... and drug-resistant,malaria. Results from several ...ed peer-reviewed journals as follows:, -- In "High...
...LADELPHIA, March 15, 2007-- The cause of one notor...to treat the ongoing,threat of another childhood d...ncer Research, researchers from Stony Brook Univer...-- form of poliovirus,is effective in obliterating...had been previously vaccinated against the virus. ...
Other Medicine Technology:Use of Sequenom's MassARRAY System Leads to Significant Scientific,Advances in Understanding Cancer, Diabetes and Drug-Resistant,Malaria 2Use of Sequenom's MassARRAY System Leads to Significant Scientific,Advances in Understanding Cancer, Diabetes and Drug-Resistant,Malaria 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 2Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 4